First Light Asset Management »

Repligen Corporation shares owned by First Light Asset Management

Quarter-by-quarter ownership of Repligen Corporation (RGEN) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Repligen Corporation

Tip: Access up to 7 years of quarterly data

All positions including Repligen Corporation held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Repligen Corporation by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $25M 166k 148.82

More positions owned by First Light Asset Management

Centessa Pharmaceuticals Common Stocks (CNTA)
Paragon 28 Common Stocks (FNA)
Evolent Health Common Stocks (EVH)
Axogen Common Stocks (AXGN)
Atricure Common Stocks (ATRC)
Insmed Common Stocks (INSM)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Xenon Pharmaceuticals Common Stocks (XENE)
Neogenomics Common Stocks (NEO)
Dyne Therapeutics Common Stocks (DYN)
Tandem Diabetes Care Common Stocks (TNDM)
Ultragenyx Pharmaceutical Common Stocks (RARE)
Performant Financial Corporation Common Stocks (PFMT)
Transmedics Group Common Stocks (TMDX)
Oscar Health Inc Class A Common Stocks (OSCR)

View all positions for First Light Asset Management

Top funds holding Repligen Corporation

BlackRock
BlackRock
T. Rowe Price Associates
Vanguard Group
State Street Corporation
Champlain Investment Partners
Sands Capital Management
Bank of New York Mellon
Macquarie Group
Brown Capital Management
Impax Asset Management Group
Invesco
Geode Capital Management
Conestoga Capital Advisors
Alliancebernstein

View all funds holding Repligen Corporation